Download PDF
Semin intervent Radiol 2011; 28(1): 032-038
DOI: 10.1055/s-0031-1273938
© Thieme Medical Publishers

Endovascular Management of Chronic Upper Extremity Deep Vein Thrombosis and Superior Vena Cava Syndrome

Patrick Warren1 , Charles Burke1
  • 1Department of Radiology, University of North Carolina, Chapel Hill, North Carolina
Further Information

Publication History

Publication Date:
22 March 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Chronic upper extremity deep vein thrombosis (UEDVT) and superior vena cava syndrome (SVCS) are important and underdiagnosed entities that are associated with significant morbidity, and both are becoming increasingly common due to the use of indwelling catheters and implantable central venous access devices. Currently, as many as 25% of patients with an indwelling catheter are diagnosed with chronic UEDVT or venous stenosis. SVCS is most commonly seen in the setting of malignancy, especially lung cancer and lymphoma. Endovascular management of chronic UEDVT and SVCS is accepted as an important first-line treatment given its high overall success rate and low morbidity as compared with medical and surgical treatments. In this article, the indications for treatment, complications, and success rates of the endovascular management of UEDVT and SVCS are reviewed. Relevant findings on presentation and physical exam as well as various imaging modalities and imaging findings are evaluated. Details of preprocedure evaluation, relevant anatomy, and avoidance of potential complications are discussed.

KEYWORDS

Upper extremity deep vein thrombosis - superior vena cava syndrome - venous stenosis - catheter-related deep vein thrombosis

REFERENCES

  • 1 Prandoni P, Polistena P, Bernardi E et al.. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications.  Arch Intern Med. 1997;  157 (1) 57-62
    CrossrefPubMedGoogle Scholar
  • 2 Becker D M, Philbrick J T, Walker IV F B. Axillary and subclavian venous thrombosis. Prognosis and treatment.  Arch Intern Med. 1991;  151 (10) 1934-1943
    CrossrefPubMedGoogle Scholar
  • 3 Hill S L, Berry R E. Subclavian vein thrombosis: a continuing challenge.  Surgery. 1990;  108 (1) 1-9
    PubMedGoogle Scholar
  • 4 De Maeseneer M, De Hert S, Van Schil P, Vanmaele R, Schoofs E. Deep venous thrombosis of the upper extremity: case reports and review of the literature.  Acta Chir Belg. 1989;  89 (5) 253-261
    PubMedGoogle Scholar
  • 5 Horattas M C, Wright D J, Fenton A H et al.. Changing concepts of deep venous thrombosis: prognosis and treatment.  Arch Intern Med. 1991;  151 1934-1943
    CrossrefPubMedGoogle Scholar
  • 6 Joffe H V, Kucher N, Tapson V F, Goldhaber S Z. Deep Vein Thrombosis (DVT) FREE Steering Committee . Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.  Circulation. 2004;  110 (12) 1605-1611
    CrossrefPubMedGoogle Scholar
  • 7 Wan J F, Bezjak A. Superior vena cava syndrome.  Hematol Oncol Clin North Am. 2010;  24 (3) 501-513
    CrossrefPubMedGoogle Scholar
  • 8 Yellin A, Rosen A, Reichert N, Lieberman Y. Superior vena cava syndrome. The myth—the facts.  Am Rev Respir Dis. 1990;  141 (5 Pt 1) 1114-1118
    PubMedGoogle Scholar
  • 9 Rizvi A Z, Kalra M, Bjarnason H, Bower T C, Schleck C, Gloviczki P. Benign superior vena cava syndrome: stenting is now the first line of treatment.  J Vasc Surg. 2008;  47 (2) 372-380
    CrossrefPubMedGoogle Scholar
  • 10 Meissner M H. Axillary-subclavian venous thrombosis.  Rev Cardiovasc Med. 2002;  3 (Suppl 2) S76-S33
    PubMedGoogle Scholar
  • 11 Lindblad B, Tengborn L, Bergqvist D. Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae.  Eur J Vasc Surg. 1988;  2 (3) 161-165
    CrossrefPubMedGoogle Scholar
  • 12 Joffe H V, Goldhaber S Z. Upper-extremity deep vein thrombosis.  Circulation. 2002;  106 (14) 1874-1880
    CrossrefPubMedGoogle Scholar
  • 13 Nemcek Jr A A. Upper extremity deep venous thrombosis: interventional management.  Tech Vasc Interv Radiol. 2004;  7 (2) 86-90
    CrossrefPubMedGoogle Scholar
  • 14 Wilson L D, Detterbeck F C, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes.  N Engl J Med. 2007;  356 (18) 1862-1869
    CrossrefPubMedGoogle Scholar
  • 15 Mayo D J. Catheter-related thrombosis.  J Intraven Nurs. 2001;  24 S13-S22
    PubMedGoogle Scholar
  • 16 Rice T W, Rodriguez R M, Light R W. The superior vena cava syndrome: clinical characteristics and evolving etiology.  Medicine (Baltimore). 2006;  85 (1) 37-42
    CrossrefPubMedGoogle Scholar
  • 17 Toglia M R, Weg J G. Venous thromboembolism during pregnancy.  N Engl J Med. 1996;  335 (2) 108-114
    CrossrefPubMedGoogle Scholar
  • 18 Bechtold R E, Wolfman N T, Karstaedt N, Choplin R H. Superior vena caval obstruction: detection using CT.  Radiology. 1985;  157 (2) 485-487
    PubMedGoogle Scholar
  • 19 Flinterman L E, Van Der Meer F J, Rosendaal F R, Doggen C J. Current perspective of venous thrombosis in the upper extremity.  J Thromb Haemost. 2008;  6 (8) 1262-1266
    CrossrefPubMedGoogle Scholar
  • 20 Rösch J, Bedell J E, Putnam J, Antonovic R, Uchida B. Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation.  Cancer. 1987;  60 (6) 1243-1246
    CrossrefPubMedGoogle Scholar
  • 21 Sculier J P, Evans W K, Feld R et al.. Superior vena caval obstruction syndrome in small cell lung cancer.  Cancer. 1986;  57 (4) 847-851
    CrossrefPubMedGoogle Scholar
  • 22 Bierdrager E, Lampmann L E, Lohle P N et al.. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy.  Neth J Med. 2005;  63 (1) 20-23
    PubMedGoogle Scholar
  • 23 Greillier L, Barlési F, Doddoli C et al.. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future ‘standard’ procedure?.  Respiration. 2004;  71 (2) 178-183
    CrossrefPubMedGoogle Scholar
  • 24 Kim Y I, Kim K S, Ko Y C et al.. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.  J Korean Med Sci. 2004;  19 (4) 519-522
    CrossrefPubMedGoogle Scholar
  • 25 Nagata T, Makutani S, Uchida H et al.. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava.  Cardiovasc Intervent Radiol. 2007;  30 (5) 959-967
    CrossrefPubMedGoogle Scholar
  • 26 Dondelinger R. Chronic upper extremity/superior vena cava venous occlusive disease. In: Mauro M, Murphy K, Thomson K, Venbrux A, Zollikofer C, eds. Image Guided Interventions. Philadelphia: Saunders Elsevier; 2008: 1055-1065
    Google Scholar
  • 27 Bornak A, Wicky S, Ris H B, Probst H, Milesi I, Corpataux J M. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions.  Eur Radiol. 2003;  13 (5) 950-956
    PubMedGoogle Scholar
  • 28 Sheikh M A, Fernandez Jr B B, Gray B H, Graham L M, Carman T L. Endovascular stenting of nonmalignant superior vena cava syndrome.  Catheter Cardiovasc Interv. 2005;  65 (3) 405-411
    CrossrefPubMedGoogle Scholar
  • 29 Oudkerk M, Kuijpers T J, Schmitz P IM, Loosveld O, de Wit R. Self-expanding metal stents for palliative treatment of superior vena caval syndrome.  Cardiovasc Intervent Radiol. 1996;  19 (3) 146-151
    CrossrefPubMedGoogle Scholar
  • 30 Bartorelli A L, Fabbiocchi F, Montorsi P, Loaldi A, Tamborini G, Sganzerla P. Successful transcatheter management of Palmaz Stent embolization after superior vena cava stenting.  Cathet Cardiovasc Diagn. 1995;  34 (2) 162-166
    CrossrefPubMedGoogle Scholar
  • 31 Rösch J, Uchida B T, Hall L D et al.. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome.  Cardiovasc Intervent Radiol. 1992;  15 (5) 319-327
    CrossrefPubMedGoogle Scholar

Patrick Warren M.D. 

Fellow, Vascular/Interventional Division, Department of Radiology, University of North Carolina

CB # 7510, Chapel Hill, NC 27599-7510

Email: pwarren@unch.unc.edu

      >